• Follow the Money: PCORI Funding, Bipolar Disorder Investments, Decentralized Trial Funding, More

    Clinical Research News | PCORI has announced $127M in investment for research projects targeting high-burden healthcare concerns; Gilde Healthcare announces a new fund for medtech; Series C for a FHIR-native health data platform; and more.

    Apr 25, 2023

  • Army Researchers Identify Blood Biomarker Panel For PTSD

    Clinical Research News | Post-traumatic stress disorder is difficult to diagnose under the best of conditions, including knowing the triggering issues and how an individual responds to stressful events. For the mostly young and “macho” men in the military who are exposed to combat and separated from their families for many months at a stretch the obstacles—and stakes—are even higher.

    Apr 20, 2023

  • AI-Based Retinal Aging Clock Gauges Effectiveness Of Anti-Aging Interventions

    Clinical Research News | Retinal scans offer a fascinating window into the health of the body’s circulatory system and brain functioning as well as identify eye diseases that aren't visibly noticeable. Now, a new study suggests that this artificial intelligence-based technology is also good for predicting how well people are aging.

    Apr 18, 2023

  • Three Ways AI Can Accelerate Innovations in Clinical Research

    Clinical Research News | Artificial Intelligence (AI-) powered software is demonstrating great potential to accelerate and improve participant screening and enrolment in clinical trials. It is also enhancing communication and collaboration between clinical research teams. These elements combined are resulting in improved productivity and better ROI for clinical trials.

    Apr 14, 2023

  • Global Collaboration Enables Headway On Rare Neuroendocrine Tumors

    Clinical Research News | Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas, which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread.

    Apr 12, 2023

  • Multi-Purpose Cancer Drug Could Extend Life Of Terminally Ill Cancer Patients

    Clinical Research News | A small company based in Norway is taking on the global-sized challenge of cancer treatment, notably including solid tumors and hematological malignancies. The means is a promising, highly specific drug, known as ATX-101, whose molecular target orchestrates many different processes in the cells.

    Apr 11, 2023